Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκkB-PUMA Signaling

Qiang Yin, Shan Liu, Anbing Dong, Xiufang Mi, Fengyun Hao, Kejun Zhang

Open source

DOI
10.12659/msm.898702
Published
2016-06-30
Container
Medical Science Monitor
Publisher
International Scientific Information, Inc.
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.12659/msm.898702,
  title = {Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκkB-PUMA Signaling},
  author = {Qiang Yin and Shan Liu and Anbing Dong and Xiufang Mi and Fengyun Hao and Kejun Zhang},
  year = {2016},
  journal = {Medical Science Monitor},
  doi = {10.12659/msm.898702},
  url = {https://doi.org/10.12659/msm.898702}
}

RIS

TY  - JOUR
TI  - Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκkB-PUMA Signaling
AU  - Qiang Yin
AU  - Shan Liu
AU  - Anbing Dong
AU  - Xiufang Mi
AU  - Fengyun Hao
AU  - Kejun Zhang
PY  - 2016
JO  - Medical Science Monitor
DO  - 10.12659/msm.898702
UR  - https://doi.org/10.12659/msm.898702
ER  - 

APA

Yin, Q., Liu, S., Dong, A., Mi, X., Hao, F., & Zhang, K. (2016). Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκkB-PUMA Signaling. Medical Science Monitor. https://doi.org/10.12659/msm.898702

Source records